279 related articles for article (PubMed ID: 18061845)
1. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of kidney proteins in streptozotocin-induced diabetic rats in response to hypoglycemic fungal polysaccharides.
Hwang HJ; Baek YM; Kim SW; Kumar GS; Cho EJ; Oh JY; Yun JW
J Microbiol Biotechnol; 2007 Dec; 17(12):2005-17. PubMed ID: 18167449
[TBL] [Abstract][Full Text] [Related]
5. Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation.
Diao WF; Chen WQ; Wu Y; Liu P; Xie XL; Li S; Shen PP; Ji J
Proteomics; 2006 Nov; 6(21):5837-45. PubMed ID: 17022097
[TBL] [Abstract][Full Text] [Related]
6. Methods of comparative proteomic profiling for disease diagnostics.
Steel LF; Haab BB; Hanash SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
8. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
9. Differential serum proteomic analysis in a model of metabolic disease.
Matsumura T; Suzuki T; Kada N; Aizawa K; Munemasa Y; Nagai R
Biochem Biophys Res Commun; 2006 Dec; 351(4):965-71. PubMed ID: 17097053
[TBL] [Abstract][Full Text] [Related]
10. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
Opatrný K
Vnitr Lek; 2004 Jul; 50(7):556-63. PubMed ID: 15323265
[TBL] [Abstract][Full Text] [Related]
11. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
[TBL] [Abstract][Full Text] [Related]
12. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
13. Proteome analysis of serum from type 2 diabetics with nephropathy.
Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
[TBL] [Abstract][Full Text] [Related]
16. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
17. Proteomics and diabetic retinopathy.
Merchant ML; Klein JB
Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats.
Gong D; Chen X; Middleditch M; Huang L; Vazhoor Amarsingh G; Reddy S; Lu J; Zhang S; Ruggiero K; Phillips AR; Cooper GJ
Proteomics; 2009 Sep; 9(18):4309-20. PubMed ID: 19634143
[TBL] [Abstract][Full Text] [Related]
19. Proteomics of mitochondrial inner and outer membranes.
Distler AM; Kerner J; Hoppel CL
Proteomics; 2008 Oct; 8(19):4066-82. PubMed ID: 18763707
[TBL] [Abstract][Full Text] [Related]
20. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
